欧洲精品一区二区三区_欧美性性性性_国产一区二区免费在线播放_日日噜噜噜噜人人爽日本精品_无套中出丰满人妻无码_国产偷窥熟女精品视频大全

Chelsea Therapeutics   
Chelsea Therapeutics International Ltd.是生技制藥公司，從事類風濕性關節炎、牛皮癬、癌癥及其它免疫系統混亂的治療用藥。該公司重點研究中的新藥CH-1504，則是一種口服型的消炎、抗癌藥物

 
Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical development company that acquires and develops innovative products for the treatment of a variety of human diseases, including central nervous system disorders. Chelsea is currently pursuing FDA approval in the U.S. for Northera? (droxidopa), a novel, late-stage, orally-active therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension in patients with primary autonomic failure.